http://onbiovc.com Your Source for BioScience Venture Capital Data Wed, 08 Feb 2012 07:00:56 +0000 http://backend.userland.com/rss092 en Oxyrane (Netherlands) a clinical-stage biopharmaceutical focused on enzyme replacement therapies for Pompe’s a lysosomal storage disease, closed a $26.5M Series D financing. Participants include Forbion Capital Partners, Morningside Group and New Science Ventures. http://onbiovc.com/oxyrane-ltd-series-d-265m/ Biocartis (Switzerland) a commercial-stage molecular diagnostics company focused on rapid biomarker identification, closed a $100M Series C financing. Participants include Debiopharm Group, Philips, Johnson & Johnson Development Corp, Wellcome Trust, Korys and Valiance. http://onbiovc.com/biocartis-sa-series-c-100m/ AcuFocus (Irvine, CA) a commercial-stage medical device company focused on corneal inlays for near-vision loss, closed a $40M Series F financing. Participants include Medtronic, SV Life Sciences, Versant Ventures, Carlyle Group, Accuitive Medical Ventures and Bausch & Lomb. http://onbiovc.com/acufocus-inc-series-f-40m/ Medivo (New York, NY) a commercial-stage healthcare data analytics company focused on organization of patient lab results, closed a $7M Series A financing. Participants include Safeguard Scientifics. http://onbiovc.com/medivo-inc-series-a-7m/ NuCana BioMed (United Kingdom) a preclinical-stage pharmaceutical company focused oncology, closed a $10.4M Series A financing. Participants include Sofinnova Partners, Morningside Ventures, Scottish Venture Fund and Alida Capital International. http://onbiovc.com/nucana-biomed-ltd-series-a-104m/ Allena Pharmaceuticals (Newton, MA) a preclinical-stage biopharmaceutical company focused on nephrologic and urologic conditions, closed a $15M Series A financing. Participants include Bessemer Venture Partners, Frazier Healthcare and Third Rock Ventures. http://onbiovc.com/allena-pharmaceuticals-inc-series-a-15m/ Cohera Medical (Pittsburgh, PA) a commercial-stage biotechnology company focused on wound management, mesh fixation and surgical tissue adhesives, closed a $25M Series C financing. Participants include Kern Whelan Capital. http://onbiovc.com/cohera-medical-inc-series-c-25m/ Pixeon (Brazil) a commercial-stage medical imaging software company focused on image processing and management, closed a $25M Series C financing. Participants include Intel Capital. http://onbiovc.com/pixeon-ltda-series-c-25m/ Sera Prognostics (Salt Lake City, UT) a development-stage diagnostic company focused on preterm birth and other pregnancy complications, closed a $19.3M Series A financing. Participants include InterWest Partners, Domain Associates, Catalyst Health Ventures, UpStart Life Sciences Capital and Osage University Partners. http://onbiovc.com/sera-prognostics-inc-series-a-193m/ Avraham Pharmaceuticals (Israel) a clinical-stage small molecule company focused on the treatment of Alzheimer’s, closed a $3M Series B financing. Participants include Yissum Research Development Foundation, Cial Biotechnology Industries and Technion Research and Development Foundation. http://onbiovc.com/avraham-pharmaceuticals-ltd-series-b-3m/ Medley Health (Dublin, CA) a commercial-stage healthcare management services company, closed a $20M Series A financing. Participants include Cardinal Partners, Technology Partners and Vivo Ventures. http://onbiovc.com/medley-health-inc-series-a-20m/ TransEnterix (San Diego, CA) a clinical-stage medical device company focused on laparoscopic systems for abdominal surgery, closed a $15M Series B financing. Participants include Aisling Capital, Quaker BioVentures, Intersouth Partners, Synergy Life Science Partners and SV Life Sciences. http://onbiovc.com/transenterix-inc-series-b-15m/ Catabasis Pharmaceuticals (Cambridge, MA) a clinical-stage biopharmaceutical company focused on fatty acid conjugated compounds for severe hypertriglyceridemia, diabetes, inflammatory and metabolic diseases, closed a $8M Series A financing bringing total round to $47.6M. Participants include SV Life Sciences, Clarus Ventures, MedImmune Ventures and Advanced Technology Ventures. http://onbiovc.com/catabasis-pharmaceuticals-inc-series-a-8m/